Home Nitros 3,4-Methylenedioxy-beta-nitrostyrene

3,4-Methylenedioxy-beta-nitrostyrene

CAS No.:
1485-00-3
Catalog Number:
AG001KYU
Molecular Formula:
C9H7NO4
Molecular Weight:
193.1562
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
10mg
≥95%
1 week
United States
$110
- +
100mg
1 week
United States
$126
- +
200mg
1 week
United States
$168
- +
500mg
1 week
United States
$279
- +
Product Description
Catalog Number:
AG001KYU
Chemical Name:
3,4-Methylenedioxy-beta-nitrostyrene
CAS Number:
1485-00-3
Molecular Formula:
C9H7NO4
Molecular Weight:
193.1562
MDL Number:
MFCD00014575
IUPAC Name:
5-[(E)-2-nitroethenyl]-1,3-benzodioxole
InChI:
InChI=1S/C9H7NO4/c11-10(12)4-3-7-1-2-8-9(5-7)14-6-13-8/h1-5H,6H2/b4-3+
InChI Key:
KFLWBZPSJQPRDD-ONEGZZNKSA-N
SMILES:
[O-][N+](=O)C=Cc1ccc2c(c1)OCO2
Properties
Complexity:
248  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
1  
Exact Mass:
193.038g/mol
Formal Charge:
0
Heavy Atom Count:
14  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
193.158g/mol
Monoisotopic Mass:
193.038g/mol
Rotatable Bond Count:
1  
Topological Polar Surface Area:
64.3A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
2.4  
Literature
Title Journal
Identification of compounds that modulate retinol signaling using a cell-based qHTS assay. Toxicology in vitro : an international journal published in association with BIBRA 20160401
Inhibiting the Inflammasome: A Chemical Perspective. Journal of medicinal chemistry 20160310
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery. The Biochemical journal 20130415
Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nature biotechnology 20111101
The synthesis and biologic evaluation of anti-platelet and cytotoxic β-nitrostyrenes. Bioorganic & medicinal chemistry 20101101
E-Combretastatin and E-resveratrol structural modifications: antimicrobial and cancer cell growth inhibitory beta-E-nitrostyrenes. Bioorganic & medicinal chemistry 20090915
Synthesis and pharmacological evaluation of novel beta-nitrostyrene derivatives as tyrosine kinase inhibitors with potent antiplatelet activity. Biochemical pharmacology 20070815
Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor. Molecular pharmacology 20061001
Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells. The Journal of biological chemistry 20020419
Properties